Does Wegovy give you heartburn — and what can you do about it?

The myth: heartburn means the treatment isn't working for you

The most common misconception our prescribers hear is that heartburn on Wegovy signals something going wrong, that it's a sign the medicine is too strong, or simply not right for you. That's not what the evidence shows. If you've been wondering whether semaglutide can give you heartburn, the short answer is yes, and it's a recognised, expected consequence of the same mechanism that makes semaglutide effective for weight management: it reduces appetite in part by slowing gastric emptying. Food and acid sit in the stomach longer, and the valve between the stomach and oesophagus can come under more pressure. The result, for some people, is reflux or a burning feeling in the chest or throat.

The NHS semaglutide medicines page lists indigestion, burping and reflux-type symptoms among the known side effects, they are not rare, and they are not a reason to assume treatment has failed. What matters is how you manage them and whether they ease as your body adjusts to the medicine.

For many people the discomfort is at its peak during the first two to four weeks on a new dose, then fades as the stomach adapts. That pattern is consistent with what was seen in the STEP clinical trial programme, which reported that GI side effects were generally mild-to-moderate and transient.

Why semaglutide and heartburn are genuinely linked

Semaglutide is a GLP-1 receptor agonist. Activating GLP-1 receptors in the gut slows the movement of food from the stomach into the small intestine, a process called gastric emptying. This is useful: food stays in the stomach longer, you feel fuller for longer, and appetite drops. But the trade-off is that elevated stomach volume and delayed clearance can push acid back up toward the oesophagus.

If you want to understand the broader picture of why semaglutide causes heartburn at a physiological level, the mechanism is the same one responsible for most of Wegovy's GI side effects, nausea, constipation, burping and indigestion included. They share a single root cause, which is why the practical advice for managing them overlaps significantly.

People who already had acid reflux or gastro-oesophageal reflux disease before starting treatment sometimes find it intensifies initially. That pre-existing history is exactly the kind of thing a prescriber needs to know about. If you are transferring to Wegovy from another treatment and have reflux, mention it at your clinical review, dose titration can be adjusted to give the gut more time to adapt. You can read more about Wegovy's full side-effect profile and how the GI effects relate to each other.

Practical steps that genuinely reduce heartburn on Wegovy

The good news is that heartburn on semaglutide responds well to behaviour changes, and most people find they can manage it without stopping treatment. The single most impactful adjustment is meal size. Large meals dramatically increase the workload on a stomach already being asked to empty more slowly, smaller, frequent meals reduce that pressure considerably.

Eating slowly helps too. Bolting food down means air and volume arrive faster than the stomach can process. Sitting upright for at least an hour after eating, avoiding food in the two to three hours before bed, and cutting back on known acid triggers (fatty meals, coffee, carbonated drinks, alcohol, spicy food) all compound the benefit. Some people find a slightly elevated sleeping position helps if night-time reflux is an issue.

For more structured guidance on managing GI symptoms while on Wegovy, our page on how to combat Wegovy side effects covers the full range, not just acid reflux. There's also specific practical detail on managing nausea on Wegovy, because nausea and heartburn often arrive together and the coping strategies overlap.

Over-the-counter antacids can provide short-term relief, but discuss them with your prescriber before relying on them regularly, some formulations can interact with the timing of other medicines, and a prescriber may prefer a different approach for persistent symptoms. The MHRA Yellow Card scheme is the right place to report any side effect that feels unexpectedly severe, not just for clinical follow-up but because that data helps refine what is known about these medicines in the real world.

When heartburn needs more than a dietary tweak

Most heartburn on Wegovy is manageable and self-limiting. But some symptoms warrant a direct conversation with your prescriber rather than waiting it out. Seek prompt medical attention if you develop severe, persistent stomach pain, particularly pain that spreads to your back or is accompanied by vomiting. That pattern can indicate pancreatitis, which is an infrequent but serious condition; the MHRA issued a specific safety communication about it in January 2026 for GLP-1 medicines as a class. Heartburn alone is different, but knowing the distinction matters.

Also speak to your prescriber if reflux is disturbing sleep consistently, if you notice difficulty swallowing, or if heartburn arrives for the first time with a new dose and doesn't ease within two to three weeks. These are not emergencies in most cases, but they are clinical conversations, not situations to self-manage indefinitely.

If you are considering starting Wegovy and have questions about whether your digestive history makes you a suitable candidate, that is exactly what the consultation process is for. Wegovy is a prescription-only medicine reviewed by a real clinician, at nume, a GPhC-registered Independent Prescriber reads every consultation personally. If you would like to explore whether treatment is appropriate for you, you can find out more about our weight-loss treatments and start a free consultation there.